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Abstract
Background: The purpose of the present study was to investigate the diagnostic value of T2-mapping in acute
myocarditis (ACM) and to define cut-off values for edema detection.
Methods: Cardiovascular magnetic resonance (CMR) data of 31 patients with ACM were retrospectively analyzed.
30 healthy volunteers (HV) served as a control. Additionally to the routine CMR protocol, T2-mapping data were
acquired at 1.5 T using a breathhold Gradient-Spin-Echo T2-mapping sequence in six short axis slices. T2-maps
were segmented according to the 16-segments AHA-model and segmental T2 values as well as the segmental
pixel-standard deviation (SD) were analyzed.
Results: Mean differences of global myocardial T2 or pixel-SD between HV and ACM patients were only small, lying
in the normal range of HV. In contrast, variation of segmental T2 values and pixel-SD was much larger in ACM
patients compared to HV. In random forests and multiple logistic regression analyses, the combination of the
highest segmental T2 value within each patient (maxT2) and the mean absolute deviation (MAD) of log-transformed
pixel-SD (madSD) over all 16 segments within each patient proved to be the best discriminators between HV and ACM
patients with an AUC of 0.85 in ROC-analysis. In classification trees, a combined cut-off of 0.22 for madSD and of 68 ms
for maxT2 resulted in 83 % specificity and 81 % sensitivity for detection of ACM.
Conclusions: The proposed cut-off values for maxT2 and madSD in the setting of ACM allow edema detection with
high sensitivity and specificity and therefore have the potential to overcome the hurdles of T2-mapping for its
integration into clinical routine.
Keywords: Cardiovascular magnetic resonance, Tissue characterization, Acute myocarditis, T2-mapping, Myocardial
edema
Background
Acute myocarditis (ACM) is one of the leading causes of
sudden cardiac death in young adults and is found in up
to 20 % of autopsy cases [1]. Moreover, it represents a
frequent precursor of dilated cardiomyopathy (DCM)
[2]. Unfortunately, clinical presentations and symptoms
largely vary, as does the clinical course of disease. The
diagnostic tools for detecting ACM lack diagnostic
sensitivity and specificity, including the current “gold
standard” endomyocardial biopsy [3]. Therefore, the
diagnosis of ACM still remains a great challenge.
During the last decade, cardiovascular magnetic res-
onance (CMR) with its unique capability of tissue
characterization has become the reference non-invasive
imaging technique for the diagnosis of ACM [4, 5]. It
has the potential to identify the various hallmarks of
myocardial inflammation, including edema, hyperemia
and fibrosis by using T2-weighted imaging, early and
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late gadolinium enhancement (EGE, LGE), referred to
as the Lake Louise consensus criteria (LL criteria) [6].
Especially imaging myocardial edema, however, remains
a great challenge as conventional qualitative T2-weighted
imaging suffers from various limitations [7, 8]. Recently,
T2-mapping has been suggested as a quantitative ap-
proach to edema imaging, allowing for a more sensitive
detection of either diffuse or even subtle changes in myo-
cardial T2 relaxation times [7, 8]. One of the main chal-
lenges of myocardial T2-mapping, however, is the high
intra- and interindividual variability of T2 times, leading
to potential difficulties in discriminating between health
and disease. While T2 is an inherent tissue property, a
recent study in healthy volunteers (HV) demonstrated
that myocardial T2 varies significantly depending on the
sequence type and field strength used [9], leading to varia-
tions of T2 times of almost 20 ms. Considering that the
difference between remote and edematous myocardium
has been reported to be in the range of 10–20 ms [7, 10],
we hypothesized that dedicated segmental reference values
are needed for a future diagnostic decision making.
The present study therefore aims at establishing a cut-
off value of myocardial T2 relaxation times for the ac-
curate detection of myocardial edema in the setting of
ACM, thereby evaluating the usefulness of the proposed
segmental reference values for the Gradient Spin Echo
(GraSE) T2-mapping sequence at 1.5 T [9]. In addition,
we previously hypothesized that ACM will result in an
increased inhomogeneity of T2 times due to its often
focal disease manifestation [9, 11]. Therefore, we intend
to analyze the diagnostic value of additional parameters
that reflect increased variability of T2 times between and
within the myocardial segments.
Methods
Study population
After obtaining approval by the Institutional Review
Board of the University Hospital of Cologne, a retro-
spective study was performed. Data sets of 31 patients
who had been consecutively referred to our department
for CMR from 2012 to 2014 after clinical diagnosis of
ACM were retrospectively analyzed in a systematic
fashion. The clinical diagnosis of ACM was based upon
the current recommendations given by the position
statement of the European Society of Cardiology Work-
ing Group on Myocardial and Pericardial Diseases [12]
(Table 1). CMR diagnosis of ACM was based upon the
presence of at least two out of three LL Criteria [6], i.e.
visually detected myocardial edema on T2-weighted im-
ages, early gadolinium enhancement or visually de-
tected LGE.
CMR data from 30 HV served as control. The status
“healthy” was based on: i) uneventful medical history,
ii) absence of any symptoms indicating cardiovascular
dysfunction iii) normal cardiac dimensions and function
proven by cine CMR, and iv) no history of inflammatory
disease including common cold virus in the last 4 weeks
before the examination [13]. We discouraged alcohol in-
take 24 h before the scans to avoid inflammatory reaction
[14]. For each volunteer written informed consent was
obtained prior to the study after approval by the local
ethics committee. Characteristics of patients and HV are
shown in Table 2.
CMR
CMR was performed on a 1.5 T MR system (Achieva
1.5 T, Philips Healthcare, Best, The Netherlands) using
a standard five-element cardiac phased array coil and
a 4-lead vectorcardiogram. A balanced steady-state free
precession (b-SSFP) sequence in breath-hold technique
and with retrospective ECG-triggering was acquired for
functional analysis. Imaging parameters were chosen as fol-
lows: repetition time (TR) 28 ms, echo time (TE) 1.4 ms,
flip angle (FA) 60°, field of view (FOV) 343 × 380 mm2,
matrix 256 × 256, slice thickness 8 mm, 50 cardiac phases.
In all patients and HV the MR protocol included three
horizontal long axes and a stack of short axes (SAX)
covering the left ventricle (LV) to assess wall motion and
Table 1 Classification of ACM patients (n = 31) according to the
current recommendations [12]
ACM (n)
Clinical presentation
Acute chest pain 23
New-onset (days up to 3 months) or worsening of:
dyspnoea at rest or exercise/fatigue, with or without left
and/or right heart failure signs
16
Palpitations/arrhythmia symptoms/syncope/aborted
sudden cardiac death
18
Cardiogenic shock 1
Diagnostic criteria
ECG/Holter/stress test features 31
Elevated TnT/TnI 26
Functional and structural abnormalities on cardiac
imaging (echo/angio/CMR)
31
Tissue characterization by CMR
Visual edema (T2-weighted imaging) 23
T2-Ratio≥1.9 [6, 22] 25
Early Enhancement Ratio (EGEr) >4 17
Visual LGE of non ischemic pattern 30
Edema + EGEr positive 1
Edema + LGE positive 9
EGEr + LGE positive 6
3 out of 3 criteria positive 15
Exclusion of CAD by coronary angiography 31
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allow for cardiac chamber quantification. Volumetry
was performed on a standard post-processing platform
(Extended MR WorkSpace, Version 2.6.3.4, Philips Health-
care, Best, The Netherlands).
Edema-sensitive black blood T2-weighted images with fat
saturation (T2 BB) in six SAX slices were used to visualize
inflammatory changes in the myocardium of HV and ACM
patients [15]. In order to detect myocardial hyperemia,
myocardial early gadolinium enhancement was assessed in
ACM patients using fast spin- echo T1-weighted images
during the first minutes after 0.1 mmol/kg Gd-DOTA
(Dotarem; Guerbet, Villepinte, France) contrast administra-
tion as previously described [16]. For the additional detec-
tion of myocardial fibrosis and scarring, LGE imaging was
performed in ACM patients 15 min after 0.2 mmol/kg
Gd-DOTA (Dotarem; Guerbet, Villepinte, France) con-
trast administration using an inversion-recovery gradient-
echo sequence in the horizontal long axes and SAX as
previously described [17].
T2-mapping
In order to cover most of the left ventricle and not to
miss focal edema, T2-mapping data were acquired in
six SAX slices evenly distributed across the LV using an
ECG-triggered, breathhold Gradient Spin Echo technique
(GraSE) [11, 18]. Image parameters were chosen as
follows: spatial resolution: 2 × 2 × 10 mm3, TR = 1 heart-
beat, nine echoes (TE1 = 15 ms, delta TE = 7.7 ms), FA 90°,
parallel imaging (SENSE = 2), EPI factor = 7, BlackBlood-
prepulse. A pixel-wise myocardial T2-map was generated
using a mono-exponential fit [7, 8, 19] on the magnitude
data using a maximum likelihood estimator (MLE), where
a Rician noise distribution was assumed.
CMR image analysis
Lake Louise criteria
Image analysis of Lake Louise Criteria was performed
using a standard post-processing platform (Extended MR
WorkSpace, Version 2.6.3.4, Philips Healthcare, Best, The
Netherlands). The myocardium was divided into 16 seg-
ments according to the AHA 16-segment model [20, 21].
Every segment was visually evaluated for presence of
myocardial edema on T2 BB imaging. Moreover, T2-ratio
was calculated as previously described [6, 22]. For calcula-
tion of the Early Gadolinium Enhancement Ratio (EGEr),
standardized myocardial and skeletal muscle regions of
interest (ROIs) were drawn on one axial slice before and
after contrast administration. EGEr was calculated as pre-
viously described [23]. Every segment was visually assessed
on LGE images and considered suspicious for myocarditis
in cases of focal signal intensity alterations with a pattern
typical for myocarditis [6].
T2-mapping
T2-map reconstruction and image analysis was done
with OsiriX viewer for Mac OS X (version 5.8.5, Pixmeo,
Bernex, Switzerland). T2-maps were calculated with a
dedicated plug-in written for the OsiriX software. An
endocardial and epicardial contour was drawn in one
original image. The trabeculated layer and the epicardial
border were left out. In doubtful cases, SSFP cine images
were consulted. The contours were copied to the other
images and aligned in each source image to correct for
respiration-induced rigid body motion. These final con-
tours were copied to the map and corrected when neces-
sary. The myocardial ROI was automatically segmented
according to the AHA 16-segment model [20, 21] and
T2 values were calculated for each segment. While
averaging all pixels within one myocardial segment for
segmental T2 calculation, the corresponding standard
deviation was recorded and assigned to an additional
parameter we refer to as “pixel-SD”.
Statistical analysis
Statistical analysis was performed in R 3.1.2 [24], using
the packages ggplot2 [25] for graphical visualization,
pastecs [26] for descriptive statistics, DAAG [27] for
cross-validation, randomForest [28] for random forests,
Table 2 Characteristics of patients and healthy volunteers
Parameter Healthy volunteers ACM patients
Number 30 31
Females/Males 16/14 6/25
Age [years] 36 ± 13 40 ± 15
Age group 20–34 years 17 15
Age group 35–49 years 9 9
Age group 50–75 years 4 7
Height [cm] 176 ± 9 175 ± 9
Weight [kg] 73 ± 14 79 ± 17
Initial TnT [μg/l] n.a. 0.56 ± 0.68
Initial NT-proBNP [pg/ml] n.a. 3201 ± 6389
Initial CK [U/l] n.a. 514 ± 609
LV enddiastolic volume/BSA [ml/m2] 80 ± 14 86 ± 15
LV endsystolic volume/BSA [ml/m2] 31 ± 8 42 ± 16
LV ejection fraction [%] 62 ± 5 55 ± 13
LV ED wall mass/BSA [g/m2]
(without papillary muscles)
44 ± 10 66 ± 12
T2-Ratio 1.7 ± 0.4 2.2 ± 0.4
T2-Ratio >1.9 10 25
Global myocardial T2 [ms] 58.7 ± 4.2 62.1 ± 7.2
Range of global T2 values [ms] 47.7–66.4 49.3–76.9
Global pixel-SD [ms] 7.7 ± 1.9 8.5 ± 2.4
Range of pixel-SD values [ms] 5.5–13.9 5.1–16.5
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rpart [29] for fitting single classification trees [30], and
ROCR [31] for ROC analyses.
All continuous data are given as mean ± standard
deviation. A p-value of < .05 was regarded as statistically
significant. Testing for significant differences between
patients and HV was performed using Welch independ-
ent T-test and Wilcoxon sum rank test. Classification
models were built using multiple as well as multinom-
inal logistic regression analyses. We further used sets of
classification trees [30] with an internal weighting by
cross validation (random forests [28]), to identify variables
that are empirically important for classification into ACM
and HV with a low misclassification rate. When assessing
variable importance using random forests, the Gini-Index
was used as a measure for impurity of classification [28].
To visualize the cut-offs that are best for the current data,
single classification trees (also known as recursive parti-
tioning) were fitted, again using the Gini-index as a meas-
ure for impurity [30]. The diagnostic accuracy of optimal
predictive parameters was evaluated using receiver operat-
ing curve (ROC) analyses.
Results
Basic demographic data
Data on clinical presentation and diagnostic criteria
according to the current recommendations [12] are
given in Table 1. Demographic characteristics of HV and
ACM patients as well as LV volumetric data, global T2
and pixel-SD values are presented in Table 2.
T2-mapping in CMR-proven ACM
Global myocardial T2 times (i.e. mean segmental T2
values averaged over all 16 segments) in ACM patients
were significantly higher compared to HV (Table 3,
Fig. 1a), although this small difference yielded an only
small to medium effect size (Table 3) and did not exceed
the normal range of T2 values in HV (Table 2). Global
myocardial pixel-SD showed a large overlap between
ACM patients and HV (Table 3, Fig. 1b).
In a previous study in HV [9], our group established
layer-specific myocardial reference T2 values for the
GraSE sequence at 1.5 T (i.e. 56.7 ± 4.1 ms for the basal,
58.1 ± 4.2 ms for the midventricular, and 62.2 ± 5.2 ms
for the apical layer). Applying these cut-off values plus a
two-fold standard deviation on the present patient co-
hort resulted in a classification of ACM patients with
26 % false-negative and 43 % false-positive results.
Increasing reference values to a cut-off plus a three-fold
standard deviation resulted in a classification with 37 %
false-negative and 23 % false-positive results.
Graphical visualization of segmental T2 values and
pixel-SD (Fig. 2) underlined that means of both parame-
ters showed no large differences. In contrast, the graph-
ics revealed that variation of T2 values and pixel-SD was
much larger in ACM patients compared to HV. Taking
into account the often focal nature of ACM, these obser-
vations led to the assumption that a cut-off neither for
average nor for layer-specific or segmental myocardial
T2 values based on reference T2-maps would be able to
reliably differentiate between health and focal disease.
Calculation of statistically derived parameters of T2 and
pixel-SD
In order to find parameters that might be able to detect
edema more reliably, we defined several parameters de-
rived from segmental T2 and log-transformed pixel-SD
values (natural logarithm), aiming at reflecting the main
aspects of focal pathologies (Fig. 3): a) the maximum seg-
mental T2 and pixel-SD value (maxT2, maxSD; defined as
the one segment of all 16 segments exhibiting the highest
segmental T2 or the highest pixel-SD value (Fig. 3a),
respectively) as sensitive parameters for single or multiple
edematous segments (and also for the case of diffuse myo-
cardial edema) and especially for a situation where only a
single segment is (partially) involved in focal edema, and
b) the mean absolute deviation (MAD) of segmental T2
and loge-transformed pixel-SD (madT2, madSD) as sensi-
tive parameters for several adjacent or non-adjacent seg-
ments only partially involved in focal myocardial edema
(Fig. 3b). The MAD is a measure of the variability between
segments (comparable to the variance between segments),
which becomes high if some segments are affected while
others are not. Because MAD measures how far (in aver-
age) the values in the single segments differ from the
overall myocardial mean, it is not affected by the high
between subject variability that had been shown in earlier
studies [9]. Moreover, MAD is a robust measure of vari-
ation not so much affected by single outlying observations
as would be the variance or standard deviation.
To avoid confusion due to the different use of the
abbreviation MAD, the definition of madSD used herein
is given in the following: denote with xj the observed
pixel-SD in the k segments within a given subject, with
index j = 1,…,k. These values have been transformed
Table 3 Means ± standard deviation, statistical significances and
effect sizes of myocardial T2, pixel-SD and statistically derived
parameters
Parameter Healthy
volunteers
ACM
patients
p-value Effect
size r
Global myocardial T2 [ms] 58.7 ± 4.2 62.1 ± 7.2 .026 .31
Global pixel-SD [ms] 7.7 ± 1.9 8.5 ± 2.4 .166 .18
maxT2 [ms] 69.6 ± 8.5 80.5 ± 16.8 .003 .43
madT2 0.07 ± 0.03 0.09 ± 0.02 .060 .26
maxSD [ms] 12.5 ± 4.2 19.0 ± 8.6 .001 .50
madSD 0.22 ± 0.05 0.29 ± 0.06 .001 .56
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using the natural logarithm, and the average has been
computed on this transformed scale.
yj ¼ loge xj
 
; y ¼
Xk
j¼1
yj
k
Then, the mean (average) absolute deviation of the
segments’ transformed values from the average on the
transformed scale is computed, without any additional
re-scaling:
madSD ¼
Xk
j¼1
yj−y


k
In the same way, madT2 has been computed as the
average absolute difference of segmental T2 values from
the overall mean of T2, but without log-transformation.
These parameters, as well as the subject-specific means
across all segments for T2 and pixel-SD were included in
further statistical analyses.
Data distribution of maxT2/maxSD and madT2/madSD
and model building
There were significant differences of maxT2, maxSD and
madSD between HV and ACM patients (Table 3, Fig. 4).
MadT2 only showed a non-significant trend towards
slightly higher values in ACM patients compared to HV
(Table 3, Fig. 4).
In exploratory random forests, madSD, madT2 and
maxT2 proved to be the best classifying parameters
according to the Gini index. In multiple logistic regres-
sion analyses, madSD and maxT2 proved to be the best
independent predictors of CMR-proven ACM (Table 4)
according to the Akaike Information Criterion (AIC). Ac-
cordingly, if madSD increased by 0.1, the odds (p(ACM)/
p(HV)) increased by factor 7.64; if maxT2 increased by 1,
Fig. 1 Box-Whisker plots representing the differences of global myocardial T2 (a) and pixel-SD (b) between HV and ACM patients. The centreline
in each box represents the median, whereas the lower and upper limits of each box represent the 25th and 75th percentiles, respectively. Whiskers
extend to the most extreme observations within 25th and 75th percentiles ± 1.5*IQR. Observations outside these whiskers are shown as dots.
*** IQR - inter-quartile-range, ACM - acute myocarditis, HV - healthy volunteers
Fig. 2 Individual variation of segmental values for myocardial T2 times (a) and pixel-SD (b) over all 16 segments, where each line represents an
individual subject, thereby comparing HV (red) and ACM patients (blue). ACM - acute myocarditis, HV - healthy volunteers
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the odds (p(ACM)/p(HV)) increased by factor 1.03. Due
to collinearity between maxT2 and madSD, however,
maxT2 was not significant when included in a model that
also contained madSD as a predictor. In a 10-fold cross-
validation, this model yielded an internal estimate of
accuracy of 0.75 and a cross-validation estimate of ac-
curacy of 0.72. The logistic regression as well as the
corresponding random forest model showed a classifi-
cation error of 27 % false-positive and 26 % false-
negative classifications.
Definition of cut-off values
For further validation and illustration, we estimated cut-
off values for both parameters, madSD and maxT2 using
classification trees [30]. This led to the definition of a
cut-off of 0.22 for madSD and of 68 ms for maxT2.
Values below both cut-offs were more likely to represent
HV, values above more likely to represent ACM. Apply-
ing both cut-offs in combination allowed a classification
of ACM patients with a sensitivity of 81 % and a specifi-
city of 83 % and showed an AUC of 0.84 in ROC-
Fig. 3 Graphical illustration of the novel concepts of maxT2/maxSD (a) and madT2/madSD (b). Each box represents one segment (1–16) of one
individual. Red dots represent focal spots of myocardial inflammation. The graphs at the bottom illustrate the corresponding individual T2/Pixel-SD
values, aufgetragen over all 16 segments in order to define maxT2/maxSD (a) as well as madT2/madSD (b). In b, black horizontal lines indicate the
mean across segments. Vertical black lines for madT2/madSD illustrate the deviations from mean that are averaged to obtain the MAD. MAD - mean
absolute deviation. Seg. - segment
Fig. 4 Box-Whisker plots representing the differences of maxT2 (a), madT2 (b), maxSD (c), and madSD (d) between HV and ACM patients. The
centreline in each box represents the median, whereas the lower and upper limits of each box represent the 25th and 75th percentiles, respectively.
Whiskers extend to the most extreme observations within 25th and 75th percentiles ± 1.5*IQR. Observations outside these whiskers are shown as dots.
*** IQR - inter-quartile-range, ACM - acute myocarditis, HV - healthy volunteers
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analysis (Fig. 5). In all 8 patients that visually did not
reveal myocardial edema, edema could be detected using
the two cut-off values. ROC-analyses for the single pa-
rameters maxT2 (67 % sensitivity, 87 % specificity) and
madSD showed an AUC of 0.76 and 0.83 (83 % sensitiv-
ity, 73 % specificity), respectively (Fig. 5).
Feasibility of the defined parameters for the diagnosis of
ACM
Figure 6 shows the profiles of segmental T2 values and
log-transformed segmental pixel SDs for three exemplar-
ily selected subjects (two ACM patients and one HV)
with corresponding representative T2 BB images and
T2-maps. Patient 1 exhibits high average T2 (80 ms),
high maxT2 (119 ms) accompanied by high pixel-SD
and madSD (0.29). This subject may represent a part of
the population of ACM patients that could be identified
on rules either based on mean T2 or maxT2, as well as
on measures of within-segment heterogeneity such as
madSD. T2 BB imaging of this patient shows no visually
apparent focal edema, whereas high maxT2 is already
apparent visually in the anterior wall of the midven-
tricular portion of the LV on the T2-map, what is in
concordance with the segmental distribution of maxT2
and madSD.
In contrast, ACM patient two shows relatively low
average T2 values (54 ms) and no extreme peak of
segmental T2-values, resulting in a maxT2 of 69 ms.
However, this patient exhibits high madSD values, indi-
cating that several segments show high within segment
T2 variability. This may be the result of an ACM focus
that is subdivided among several segments, so that none
of the affected segments shows an extraordinarily high
T2 but all affected segments show a high positive devi-
ation from the mean pixel-SD. The high intramyocardial
inhomogeneity is also visible on the T2-map, whereas
T2 BB imaging shows neither an unequivocal focal nor a
diffuse rise of signal intensity.
Finally, the selected HV shows low average T2 (59 ms),
segmental T2 values with only low deviations from the
average T2 and only limited variation of within segment
heterogeneity. The corresponding T2-map reflects low
myocardial T2 as well as relative homogeneous myocar-
dial T2.
Relation of diagnostic parameters to laboratory testing
Patients with CMR-proven ACM showed a mean initial
Troponin T (TnT) of 0.59 μg/l, a mean initial brain
natriuretic peptide (NT-proBNP) of 3201 pg/ml and a
mean initial creatine kinase (CK) of 514 U/l. Patients
diagnosed with ACM according to the above defined
criteria (maxT2 >68 ms +madSD >0.22, n = 21) exhibited
higher initial TnT values compared to the remaining
CMR-proven ACM patients, although this difference was
not significant at the 5 % level (0.59 ± 0.71 vs. 0.48 ± 0.62,
p = .641). Patients with pathologic T2 values according
to the definition showed significantly higher initial NT-
proBNP values (3650 ± 6780 vs. 279 ± 186 pg/ml, p = .038)
as well as a non-significant trend towards higher CK
values (572 ± 673 vs. 331 ± 309 U/l, p = .500).
Discussion
Myocardial edema is an important pathophysiological
component in many acute heart diseases such as myo-
carditis. T2-mapping may allow for a more sensitive and
objective detection of changes in myocardial water
content by means of altered T2 relaxation times [7, 8].
Its integration into clinical routine, however, is still
hindered by several limitations, despite some previous
attempts to define appropriate cut-off values for myo-
cardial T2 times [7, 32–35]. In addition, several studies
have presented partially contradictory results with respect
to the diagnostic potential of T2-mapping in the setting of
myocarditis [7, 33, 34, 36]. In the present study, we sought
to address one of the main challenges of T2-mapping, i.e.
the high intra- and interindividual variability of T2
times that so far have led to difficulties in discriminating
Fig. 5 ROC-Analysis for differentiating CMR-proven ACM patients
from HV. ACM - acute myocarditis, HV - healthy volunteers
Table 4 Multiple logistic regression model
95 % CI for odds ratio
B (SE) Lower Odds ratio Upper
Intercept −7.00
maxT2 0.03 0.97 1.03 1.10
madSD 20.34 2.30 7.64 32.71
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between health and disease. We hereby present a potential
novel diagnostic parameter, madSD that is aimed at
reflecting the inhomogeneity of myocardial tissue due to
inflammatory changes, as further discussed below. In
addition, we present dedicated cut-off values for madSD
in combination with maximal segmental T2 (maxT2),
aiming at a more sensitive and specific detection of myo-
cardial edema in the setting of ACM.
Fig. 6 Segmental T2 (first row), log-transformed pixel-SD (second row), T2 black-blood images of one short axis slice, and corresponding T2-maps
for 4 selected subjects. Black horizontal lines indicate the mean across segments. Vertical black lines for madSD illustrate the deviations from mean
that are averaged to obtain madSD
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There have been several attempts and different ap-
proaches to bring T2-mapping towards clinical routine
in the setting of myocarditis. Thavendiranathan et al. [7]
established a cut-off of 59 ms for myocardial T2 using
the T2prep sequence [8] by averaging T2 over segments
rated as “involved”/“not involved” visually as well as by
relying on wall motion abnormalities. Wassmuth et al.
defined a similar cut-off of 60 ms for T2prep while com-
paring T2 of remote and edematous segments of ACM
patients [35]. Butler et al. published a cut-off of 59 ms
that was able to predict biopsy-proven myocarditis using
a multi echo spin echo approach (MESE) by drawing a
single ROI in the septum [32]. Trying to establish a
single cut-off for myocardial T2 by using the rule “refer-
ence value plus 2- or 3-fold SD” in our study, however,
resulted in unsatisfactory classification rates of “healthy”
and “ACM” with either too many false-positive or false-
negative classifications.
All these approaches have a common major limitation:
averaging myocardial T2 over many segments or using
only one septal ROI does not take into account the often
focal nature of myocarditis. Small edematous changes
that can be distributed diffusely or focally throughout
the whole myocardium, thereby involving only small
parts of many different segments may easily be over-
looked when “averaging” T2 values.
Thavendiranathan et al. already noted a wider distribu-
tion of T2 values in edematous regions and discussed
that this may reflect heterogeneity in tissue changes, just
as there is an epicardial predominance of injury by LGE
[7]. In the present study, we aimed to account for such
an increased inhomogeneity in myocardial water content
by elaborating on the potential of parameters like pixel-SD
and madSD as novel diagnostic criteria in the diagnosis of
ACM. The good diagnostic performance achieved by a
combination of madSD and maxT2 favors our hypothesis
that the combination of these parameters adequately re-
flects the different manifestations of myocardial edema in
ACM, i.e. i) a focus that is confined to one or a couple of
adjacent segments resulting in an increased segmental T2
and increased inhomogeneity, ii) a focus that is subdivided
among several segments, leading to increased inhomogen-
eity but normal overall segmental and global T2 values,
and iii) a diffuse edematous process that may be detected
by either of the two parameters maxT2 and madSD. Our
data for the present patient cohort indicate, however, that
maxT2 might play only a minor, although not negligible
role for the detection of myocardial edema: in sequential
tests of logistic regression models, madSD showed a
significant effect when maxT2 was already accounted for;
conversely, maxT2 did not show an additional significant
effect when added to a model that did already contain the
predictor madSD. Moreover, ROC analysis showed that
classification according to madSD always resulted in
higher or equal true positive rates than classifications
according to maxT2. The importance of both parameters
as well as the defined cut-offs therefore need further valid-
ation in a larger study cohort.
In addition, further studies should look to what extent
madSD is influenced by the sequence type and field
strength. Applying madSD and maxT2 in a larger patient
cohort at 3 T and using different sequence types there-
fore would be of great interest to future research.
The clinical implications of abnormal myocardial T2
still remain unclear. Nevertheless, they are believed to
reflect reversible pathology [37]. In patients with clinic-
ally suspected acute myocarditis, myocardial edema has
been associated with LV function recovery, indicating
that the observed increase of EF may be due to the
recovery of reversibly injured (edematous) myocardium
[38]. Further studies should investigate this association
of edematous myocardium with functional recovery as
well as the potential prognostic implications of edema
imaging.
We observed a certain association of the presence of
myocardial edema defined by the novel diagnostic criteria
with the serum levels of different cardiac biomarkers.
Similar observations had also been reported previously in
a conference abstract [39]. Whether myocardial T2 alter-
ations are directly related to the biochemical severity of
myocarditis, as suggested by our results, remains to be
confirmed in future studies.
Only 23 out of 31 ACM patients demonstrated visual
edema on T2 BB images, although none of the HV
showed false-positive signal alterations in a pure visual
analysis. Performing a semi-quantitative analysis as it is
recommended in the LL criteria by calculating the T2-
ratio [6, 22] resulted in two more cases diagnosed with
edema (25 out of 31), but also in 10 out of 30 HV show-
ing a false-positive T2-ratio >1.9. These observations
underline that both, qualitative and semi-quantitative
T2-weighted imaging are limited by moderate sensitiv-
ities and/or specificities and should be replaced in the
future by more reliable quantitative techniques such as
T2-mapping.
Study limitations
The results shown here are explorative and need further
confirmation, re-estimation of model coefficients or cut-
off values as well as validation in future studies with
larger patient cohorts.
We did not perform EMB in our patient cohort, but
decided to use a CMR-based approach in consideration
of the LL criteria [6] for confirmation of the clinical
diagnosis “ACM”. Therefore, CMR with LL criteria served
as our reference method, what represents a realistic ap-
proach for clinical routine in the setting of ACM, where
EMB is limited by its invasiveness and by the possible
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associated inherent procedural risks and therefore per-
formed only in the minority of cases with specific indica-
tions [40]. Therefore, our study design takes into account
the more and more prominent role of CMR in the diag-
nostic work-up of ACM that potentially may lead towards
a redefinition of the diagnostic gold standard in the future
[41] when including more non-invasive imaging criteria to
confirm the diagnosis.
Our approach using CMR with LL criteria as a refer-
ence leads to another study limitation: as the presence of
two out of three LL criteria was the criterion for patients
to be included in the study, we were not able to compare
the diagnostic potential of T2-mapping to LL criteria, as
those had an artificial sensitivity and specificity of nearly
100 %. This should be completed in a further validation
study investigating the additional diagnostic value of
T2-mapping to LL criteria.
Conclusions
Establishing a timely and correct diagnosis in the setting
of acute myocarditis remains a challenging task and any
improvements in diagnostic performance and confidence
are highly desirable. Previous attempts to detect and
objectify myocardial edema as one of the hallmarks of
acute inflammation by means of myocardial T2 mapping
have given mixed results also because of a large overlap
of absolute T2 values in disease and health. In our study,
we suggest a novel approach to the quantitative analysis
of T2 maps. By means of a set of parameters that better
account for the inhomogeneity of disease manifestation
in acute myocarditis we were able to define cut-off
values for derived T2 measures (maxT2 and madSD)
that, if combined, exhibit high diagnostic sensitivity and
specificity in patients with CMR-proven ACM. If con-
firmed by future studies, this set of parameters hold the
potential to overcome the hurdles of T2-mapping and
promise to make it into a valuable tool in the routine
diagnostic work-up for ACM.
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